Citigroup Downgrades Agilon Health to Sell, Raises Price Target to $105

Benzinga · 1d ago
Citigroup analyst Daniel Grosslight downgrades Agilon Health (NYSE:AGL) from Neutral to Sell and raises the price target from $80 to $105.